Table 3.

Projects noting future use of DNA for product development or commercialization

Project No.	Drug/product development		Commercialization
	yes, n (%)	no, n (%)	yes, n (%)	no, n (%)
1	0 (0.000)	1 (0.056)	0 (0.000)	1 (0.056)
2	0 (0.000)	1 (0.056)	0 (0.000)	1 (0.056)
3	0 (0.000)	1 (0.056)	1 (0.056)	0 (0.000)
4	0 (0.000)	1 (0.056)	0 (0.000)	1 (0.056)
5	0 (0.000)	1 (0.056)	0 (0.000)	1 (0.056)
6	1 (0.056)	0 (0.000)	1 (0.056)	0 (0.000)
7	0 (0.000)	1 (0.056)	0 (0.000)	1 (0.056)
8	1 (0.056)	0 (0.000)	1 (0.056)	0 (0.000)
9	1 (0.056)	0 (0.000)	0 (0.000)	1 (0.056)
10	1 (0.056)	0 (0.000)	0 (0.000)	1 (0.056)
11	0 (0.000)	1 (0.056)	1 (0.056)	0 (0.000)
12	1 (0.056)	0 (0.000)	0 (0.000)	1 (0.056)
13	1 (0.056)	0 (0.000)	0 (0.000)	1 (0.056)
14	0 (0.000)	1 (0.056)	0 (0.000)	1 (0.056)
15	0 (0.000)	1 (0.056)	0 (0.000)	1 (0.056)
16	0 (0.000)	1 (0.056)	0 (0.000)	1 (0.056)
17	1 (0.056)	0 (0.000)	0 (0.000)	1 (0.056)
18	0 (0.000)	1 (0.056)	0 (0.000)	1 (0.056)
18 total projects	7 (0.388)	11 (0.611)	4 (0.222)	14 (0.777)